Could Pharmaceutical Companies Benefit from Crowdsourcing?

Read Transcript

Then that's the big question, Mark, right? So pharmaceutical companies need to start getting into business of building experiences for those rare diseases. So if they're not going to be in the drug discovery business for that certain patient population where can they put a stick in the ground to help say you know what, we are actually going to build better experiences for these patients potentially fighting new revenue models besides the selling of molecules.